Skip to main content

Life Sciences & Healthcare

The Life Sciences & Healthcare industry group strives to support clients in addressing the challenges that impact today’s industry.

Unleash AI's potential

Measuring the return from pharmaceutical innovation

 

Our 14th annual report tracks the returns on R&D investment that the largest biopharma companies might expect to achieve from their late-stage pipelines. This analysis shows that this conclusion is more relevant than ever, given that companies are facing a more challenging regulatory landscape, growing cost pressures, declining peak sales and difficulties in replenishing their pipelines, with the result that projected R&D returns continue to remain well below the cost of capital.

Explore the latest findings >

Life Sciences Connect

Life Sciences Connect explores the big issues, emerging trends and cutting-edge innovations shaping the life sciences and healthcare industries. Tune in to hear the latest insight from our Centre for Health Solutions team, Deloitte leaders and key players across Pharma, Biotech, MedTech and Healthcare.